{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Miljöinformationen för betametason är framtagen av företaget GlaxoSmithKline för Betnovat®, Betnovat® med chinoform, Betnovat® med neomycin Miljörisk: Risk för miljöpåverkan av betametason kan inte uteslutas då det inte finns tillräckliga ekotoxikologiska data. Nedbrytning: Betametason är potentiellt persistent. Bioackumulering: Betametason har låg potential att bioackumuleras. Läs mer Detaljerad miljöinformation Detailed background information Environmental Risk Classification Predicted Environmental Concentration (PEC) PEC is calculated according to the following formula: PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A(100-R) PEC = 0.064 μg/L Where: A = 465.29 kg (total sold amount API free base in Sweden year 2022, data from IQVIA). Total volume of Betametasone acetate = 0.23 = 0.21 Kg acetate free base. Total volume of Betametasone dipropionate = 473 = 368 Kg dipropionate free base. Total volume of Betametasone sodium phosphate = 25 = 19 Kg atrium phosphate free base. Total volume of Betametasone valerate = 69.57 = 57.29 Kg valerate free base. R = 0% removal rate (conservatively, it has been assumed there is no loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation). P = number of inhabitants in Sweden = 10*106 V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference 1) D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Reference 1) Predicted No Effect Concentration (PNEC) Ecotoxicological studies Algae: No data Water flea (Daphnia magna): Acute toxicity EC50 48 h (immobility) = 1,900 µg/L (OECD 202) (Reference 3) Water flea: Chronic toxicity No data Fish: Acute toxicity No data Chronic toxicity No data Other ecotoxicity data: Microorganisms in activated sludge: EC50 3 h (inhibition) > 1,000,000 µg/L (OECD 209) (Reference 4) NOEC 3 h (inhibition) = 1,000,000 PNEC cannot be calculated because data is not available for all three (algae, crustacean and fish) of the toxicity endpoints. Environmental risk classification (PEC/PNEC ratio) Risk of environmental impact of betamethasone cannot be excluded, since there is not sufficient ecotoxicity data available. Degradation Biotic degradation Ready degradability: No data Inherent degradability: 28% primary degradation in 28 days (OECD 302C) (Reference 5) Abiotic degradation Hydrolysis: 50% degradation (pH 7) = 6.5 days (TAD 3.09) (Reference 7) Photolysis: No data Justification of chosen degradation phrase: Betamethasone valerate is not readily degradable or inherently biodegradable but the parent API undergoes appreciable primary biodegradation. This substance is predicted to degrade via hydrolysis with a half-life is less than 40 days. However, relevant hydrolysis products have not been identified and characterised. The phrase “betamethasone valerate is potentially persistent” is thus chosen. Bioaccumulation Bioconcentration factor (BCF): Partitioning coefficient: Log Pow = 3.60 (OECD 107). (Reference 6) Justification of chosen bioaccumulation phrase: Since log Pow < 4, the substance has low potential for bioaccumulation. Excretion (metabolism) Betamethasone:Topical mode of administration with up 14 % of betamethasone adsorbed systematically. This fraction is extensively metabolised in the liver. Only 4.8 % of the dose is recovered from urine, the remainder is eliminated as metabolites (Reference 2). Please, also see Safety data sheets on http://www.msds-gsk.com/ExtMSDSlist.asp. . References ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. Petersen MC, Nation RL, McBride WG, et al: Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 1983; 25:643-650. Sewell IG and McKenzie J. Betamethasone 17-Valerate: Acute Toxicity to Daphnia magna. Report No. 1127/304. Safepharm Laboratories Limited, May 2004. Clarke N. Betamethasone 17-Valerate: Assessment of the Inhibitory Effect on the Respiration of Activated Sewage Sludge. Report No. 1127/306. Safepharm Laboratories Limited, May 2004. Mead C and McKenzie J. Betamethasone 17-Valerate: Assessment of Inherent Biodegradability; Modified MITI (II) Test. Report No. 1127/305. Safepharm Laboratories Limited, July 2004. Dołowy M, Pyka A. Evaluation of Lipophilic Properties of Betamethasone and Related Compounds. Acta Pol Pharm. 2015;72(4):671-681 Material Safety Data Sheet for Betnovate® GM Cream. SDS number 130046. GlaxoSmithKline plc, September 2007."
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "Betametason/Salicylsyra Orifarm, Salva 0,5 mg/g + 30 mg/g"
    }
}